BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35645114)

  • 1. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
    Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
    J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
    Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
    Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
    Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
    Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
    Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
    Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
    Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
    Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.
    Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH
    Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma.
    Prasoppokakorn T; Buntho A; Ingrungruanglert P; Tiyarattanachai T; Jaihan T; Kulkraisri K; Ariyaskul D; Phathong C; Israsena N; Rerknimitr R; Treeprasertsuk S; Chaiteerakij R
    Sci Rep; 2022 Nov; 12(1):18686. PubMed ID: 36333384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
    Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
    Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
    Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
    Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells as a window on metastasis biology in lung cancer.
    Hou JM; Krebs M; Ward T; Sloane R; Priest L; Hughes A; Clack G; Ranson M; Blackhall F; Dive C
    Am J Pathol; 2011 Mar; 178(3):989-96. PubMed ID: 21356352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.